Appendix C
Meeting One Agenda

Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic


Meeting 1

December 3–4, 2007

National Academy of Sciences Building

2101 Constitution Avenue, NW

Washington, DC

AGENDA

December 3, 2007

Auditorium

1:00 pm

Welcome, Committee Introductions, and Opening Comments

June Osborn

Committee Chair

Background

1:15 pm

Charge to the Committee

Guidance on Use of Antiviral Drugs and Planning Assumptions

Benjamin Schwartz

Senior Science Advisor

National Vaccine Program Office

Department of Health and Human Services

1:45 pm

Committee Questions



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 107
Appendix C Meeting One Agenda Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic Meeting 1 December 3–, 2007 National Academy of Sciences Building 2101 Constitution Avenue, NW Washington, DC AGENDA December , 00 Auditorium 1:00 pm Welcome, Committee Introductions, and Opening Comments June Osborn Committee Chair Background 1:15 pm Charge to the Committee Guidance on Use of Antiviral Drugs and Planning Assumptions Benjamin Schwartz Senior Science Advisor National Vaccine Program Office Department of Health and Human Services 1:45 pm Committee Questions 0

OCR for page 107
0 ANTIVIRALS FOR PANDEMIC INFLUENZA 2:15 pm Primer on Antiviral Drug Effectiveness and Resistance Fred Hayden World Health Organization Professor of Internal Medicine and Pathology Department of Medicine Division of Infectious Diseases and International Health University of Virginia Health System Infectious Diseases Society of America 2:45 pm Committee Questions 3:00 pm Antiviral Drug Stockpiling and Distribution Planning Anita Patel Health Scientist Lockheed Martin Information Technology Contractor assigned to Division of Strategic National Stockpile Coordinating Office of Terrorism Preparedness and Emergency Response Centers for Disease Control and Prevention 3:15 pm Committee Questions 3:30 pm Legal Issues in an Influenza Pandemic James G. Hodge Associate Professor Johns Hopkins Bloomberg School of Public Health Executive Director and Principal Investigator Centers for Law and the Public’s Health: A Collaborative Core Faculty, Johns Hopkins Berman Institute of Bioethics 3:45 pm Committee Questions 4:00 pm Break Panel 1: Diagnosing Influenza 4:15 pm Diagnosis in Children John Bradley Director of the Division of Infectious Diseases Children’s Hospital, San Diego American Academy of Pediatrics Infectious Diseases Society of America

OCR for page 107
0 APPENDIX C 4:30 pm Diagnosis in Adults Andrew Pavia George and Esther Gross Presidential Professor Chief of the Division of Pediatric Infectious Diseases University of Utah Health Sciences Center and Primary Children’s of Utah Infectious Diseases Society of America Member of the Institute of Medicine Committee 4:45 pm Other Diagnostic Issues Marie Griffin Professor of Preventive Medicine Professor of Medicine Vanderbilt University School of Medicine 5:00 pm Infection Control in the Waiting Room Richard Clover Dean School of Public Health and Information Sciences University of Louisville 5:15 pm Committee Questions and Discussion with Panel 5:45 pm Adjourn December , 00 Lecture Room 8:00 am Welcome June Osborn Committee Chair Panel 2: Treating Cases and Providing Post-Exposure Prophylaxis to Their Household Contacts 8:15 am Federal, State, and Local Laws Regarding Prescribing and Dispensing Stephen W. Schondelmeyer Chair Department of Pharmaceutical Care Health Care Systems Professor of Pharmaceutical Economics Century Mortar Club Endowed Chair in Pharmaceutical Management University of Minnesota

OCR for page 107
0 ANTIVIRALS FOR PANDEMIC INFLUENZA 8:30 am Federal Regulatory Perspective Barbara A. Styrt Medical Officer Division of Antiviral Drug Products Office of Antimicrobial Products Office of New Drugs Center for Drug Evaluation and Research Food and Drug Administration 8:45 am Role of Pharmacies Catherine M. Polley Vice President Pharmacy Services Food Marketing Institute 9:00 am Other Issues Related to Dispensing Prophylaxis Tammy Robertson Operations Manager, Fedex Custom Critical 9:15 am Committee Questions and Discussion with Panel 9:45 am Break Panel 3: State and Local Planning 10:00 am State Planning (overview, considerations, and examples) Donald E. Williamson Health Officer Alabama State Department of Health 10:30 am Local Planning (overview, considerations, and examples) Jane Zucker Assistant Commissioner Bureau of Immunization New York City Department of Health and Mental Hygiene Paul Biedrzycki Director Disease Control and Prevention City of Milwaukee Health Department

OCR for page 107
 APPENDIX C Junie Delizo Director Emergency Preparedness Rockland County (NY) Department of Health 11:30 am Committee Questions and Discussion with Panel 12:00 pm Lunch Panel : Outbreak Prophylaxis of Health Care Workers 1:00 pm Hospital-Based Prophylaxis Allison McGeer Microbiologist, Infectious Disease Consultant Mount Sinai Hospital Toronto, Ontario Professor Departments of Laboratory Medicine and Pathobiology Department of Public Health Sciences University of Toronto Stephen R. Pitts Attending Physician, Emory Crawford Long Hospital Emergency Department Associate Professor Department of Emergency Medicine Emory University School of Medicine on sabbatical as AcademyHealth Fellow National Center for Health Statistics 1:45 pm Prophylaxis at Outpatient Sites Douglas Campos-Outcalt Clinical Professor and Associate Chair Department of Family and Community Medicine University of Arizona College of Medicine American Academy of Family Physicians 2:00 pm Long-Term Care Facilities Janice Zalen Director of Special Programs American Health Care Association

OCR for page 107
 ANTIVIRALS FOR PANDEMIC INFLUENZA 2:30 pm Health Care Worker Labor Issues Katherine Cox Health Policy Analyst American Federation of State, County and Municipal Employees International 2:45 pm Committee Questions and Discussion with Panel 3:00 pm Break Panel 5: Outbreak Prophylaxis in Emergency Service Organizations (fire, police, emergency medical services) 3:15 pm Emergency Medical Services (EMS) Kathy Robinson Program Advisor National Association of State EMS Officials 3:30 pm Fire John Delaney Captain Fire Department Arlington County, VA 4:00 pm Committee Questions and Discussion with Panel 4:30 pm Adjourn